Supriya Lifescience standalone net profit declines 3.40% in the March 2024 quarter

Sales rise 11.18% to Rs 158.18 crore

Net profit of Supriya Lifescience declined 3.40% to Rs 36.93 crore in the quarter ended March 2024 as against Rs 38.23 crore during the previous quarter ended March 2023. Sales rose 11.18% to Rs 158.18 crore in the quarter ended March 2024 as against Rs 142.27 crore during the previous quarter ended March 2023.

For the full year,net profit rose 32.55% to Rs 119.11 crore in the year ended March 2024 as against Rs 89.86 crore during the previous year ended March 2023. Sales rose 23.74% to Rs 570.37 crore in the year ended March 2024 as against Rs 460.94 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear EndedMar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.Sales158.18142.27 11 570.37460.94 24 OPM %35.0838.69 -30.3327.96 - PBDT57.0856.30 1 181.50135.31 34 PBT53.1753.29 0 165.69123.49 34 NP36.9338.23 -3 119.1189.86 33

Powered by Capital Market - Live News